Screening of natural compounds and their derivatives as potential protein kinase C inhibitors
- 1 October 2004
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 63 (2) , 76-87
Abstract
Protein kinase C (PKC) isozymes are important signal transducers in a number of cellular responses that makes PKC inhibition a topical target for drug discovery. In this study, a set of natural compounds and their derivatives (43 in total) were screened to establish their potential inhibitory effects on PKC, exploiting kinase activity and [3H]‐phorbol ester binding assays. Statistical evaluation of the assays yielded signal‐to‐background, signal‐to‐noise, and Z′ values of 16.1, 11.3, and 0.62, respectively, for the kinase activity assay and 47.4, 15.9, and 0.73 for the binding assay, demonstrating their suitability for screening. Of the compounds investigated, the most potent PKC inhibitor was (−)‐epigallocatechin gallate (EGCG), which had an IC50 of 4.8 µM. In addition, (−)‐epicatechin gallate, dodecyl gallate, and the flavonoids myricetin, quercetin, rhamnetin, luteolin, isorhamnetin, and kaempferol were effective while naringin and scopoletin demonstrated negligible effects. None of the compounds was able to significantly inhibit the binding of phorbol ester to the regulatory domain of PKCα. The highest inhibition, 59%, was observed in the case of EGCG at a concentration of 150 µM. Taken together, nine PKC inhibitors were identified, none of which was able to compete with the binding of phorbol ester to PKCα, suggesting that the mechanism of PKC inhibition could be a result of binding to the catalytic domain of PKC. Drug Dev Res 63:76–87, 2004.Keywords
Funding Information
- National Technology Agency of Finland (40708/00 and 40045/02)
- Graduate School in Pharmaceutical Research in Finland
- Finnish Academy (80772)
- Magnus Ehrnrooth Foundation
This publication has 48 references indexed in Scilit:
- Gene expression profile in human prostate LNCaP cancer cells by (−) epigallocatechin-3-gallateCancer Letters, 2002
- Daphnetin, One of Coumarin Derivatives, Is a Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1999
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Inhibition of Eukaryote Serine/Threonine-Specific Protein Kinases by PiceatannolPlanta Medica, 1998
- Design of Signal Windows in High Throughput Screening Assays for Drug DiscoverySLAS Discovery, 1997
- Screening of anticarcinogenic ingredients in tea polyphenolsCancer Letters, 1997
- Specific inhibition of cyclic amp-dependent protein kinase by warangalone and robustic acidPhytochemistry, 1997
- Inhibitory effects of phytopolyphenols on TPA‐induced transformation, PKC activation, andc‐junexpression in mouse fibroblast cellsNutrition and Cancer, 1997
- The Protein Kinase C Family in the Brain: Heterogeneity and Its ImplicationsAnnals of the New York Academy of Sciences, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976